What does a negative strip of black-and-white film, a figure at Madame Tussaud’s Wax Museum, and a large missile on the grounds of the San Diego Air & Space Museum have in common? They all represent a piece of U.S. history with an amazing back-story! Veteran Travel Channel host Don Wildman provides a unique glimpse at America’s museums by unraveling unknown layers of the nation’s past. With the sixth season of “Mysteries at the Museum” launching on Thursday, January 2 at 9:00 p.m. ET/PT, the original series remains a fan favorite with Travel Channel’s viewers. In each of the 13 one-hour episodes, Wildman brings six artifacts to life through their intriguing stories. Viewers take a fascinating journey to the historical institutions that millions visit as part of their travel itinerary.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/64286-travel-channel-mysteries-at-the-museum-host-don-wildman-uncovers-stories
Looking to build a new home that would gracefully transition into a full-time, eco-friendly residence, Warren and Sally Baker turned to Blu® Homes, Inc. (“Blu”), the leading builder of precision-engineered, green prefab homes. The Bakers will build a one-story, green home with Blu Homes that is strong enough to weather storms and hurricanes that are common to coastal regions. The Baker home will be Blu Homes’ first project built on Shelter Island.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/64404-blu-homes-to-build-first-home-on-shelter-island
The first comprehensive long-term study comparing different medications for type 2 diabetes is launching nationwide. The GRADE (Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness) Study will compare the long-term benefits and risks of four widely used diabetes drugs in combination with metformin, the most common first-line medication for treating type 2 diabetes.
To view Multimedia News Release, go to http://www.multivu.com/mnr/64578-grade-glycemia-reduction-approaches-in-diabetes-comparative-effectiveness
Lung cancer is the most common cause of cancer-related death worldwide, with the highly malignant small cell lung cancer having the worst prognosis. In recent years the surge of immunotherapy has given cancer sufferers new hope.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/64826-issels-recurrent-lung-cancer-responds-to-integrative-immunotherapy
Lung cancer is the most common cause of cancer-related death worldwide, with the highly malignant small cell lung cancer having the worst prognosis. In recent years the surge of immunotherapy has given cancer sufferers new hope.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/65511-issels-integrative-immunotherapy-non-toxic-treatment-lung-cancer
As the cold and flu season peaks, adults may take multiple over-the-counter (OTC) pain medicines to treat their pain and fever symptoms. Yet many are unaware of the serious liver or gastrointestinal damage that can result from the overdose or overuse of common OTC pain medicine ingredients. To help adults safely take these medicines, the American Gastroenterological Association (AGA) today launched Gut Check: Know Your Medicine, an education campaign focused on the safe use of OTC products. Central to the campaign is a unique flipbook-style video that highlights the importance of reading and following OTC medicine labels.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/65680-american-gastroenterological-aga-gut-check-know-your-medicine-otc-psa
Last-minute tax filers often fall victim to common tax errors either by overpaying a preparer, missing credits/deductions, or making math errors. With the tax filing deadline less than a week away, one of the best ways for eligible tax filers to save money, maximize their refunds and get their refunds quickly is to file for free with MyFreeTaxes.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/7169451-myfreetaxes-non-profit-free-tax-filing
Jeffrey Bacha, president and CEO of DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) (“DelMar Pharma” or “DelMar”) discusses new clinical research and treatments in development for glioblastoma, the most common and severe form of brain cancer. Less than one out of three patients will survive two years after their diagnosis. DelMar is a cancer-focused company developing new therapies for patients with little to no treatment options.
To view the Multimedia News Release, go to: http://www.multivu.com/mnr/7037951-delmar-pharmaceuticals-glioblastoma-brain-tumor-awareness-month
Lung cancer is the most common cause of cancer-related death worldwide, with the highly malignant small cell lung cancer having the worst prognosis. In recent years the surge of immunotherapy has given cancer sufferers new hope. While several leading cancer centers have only begun introducing immunotherapy, Issels has been a leader in Integrative Immunotherapy for decades.
To view the Multimedia News Release, go to: http://www.multivu.com/mnr/7224051-issels-integrative-immunotherapy-lung-cancer-advanced-treatment
NI (Nasdaq: NATI) today announced VirtualBench, an all-in-one instrument that integrates a mixed-signal oscilloscope, function generator, digital multimeter, programmable DC power supply and digital I/O. Users interact with VirtualBench through software applications that run on PCs or iPads. The device provides the most common functionality affordably and opens up new possibilities for how engineers can use benchtop instruments.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/7230751-ni-reshapes-instrumentation-with-software-based-device-virtualbench
Volvo Cars’ all-new XC90 – which will be revealed in August – will offer the most comprehensive and technologically sophisticated standard safety package available in the automotive industry. The new technologies will take the company a significant step closer to its vision that no one will be killed or seriously injured in a new Volvo car by 2020.
The XC90 is the first car in the world with technology that features automatic braking if the driver turns in front of an oncoming car. This is a common scenario at busy city crossings as well as on highways, where the speed limits are higher. The all-new Volvo XC90 detects a potential crash and brakes automatically in order to avoid a collision or mitigate the consequences of a crash.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/71400582-all-new-volvo-XC90-safest-car
AstraZeneca announced today that it has collaborated with actor and father James Van Der Beek on a campaign to dispel common myths about the flu and underscore the importance of annual influenza vaccination for eligible individuals and families. As part of the campaign, Van Der Beek stars in an informative and comedic video, called “Just the Flu Facts,” in which he uses his signature sense of humor to debunk common misconceptions about seasonal influenza that are often barriers to vaccination.
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7312451-medimmune-specialty-care-james-van-der-beek-flumist-quadrivalent-encourage-flu-shot/
